Journey Medical targets expanded Emrosi coverage and EBITDA growth through 2026 amid robust prescription demand (NASDAQ:DERM)March 26, 2026
Share Facebook Twitter LinkedIn Pinterest Email How clinicians worldwide are delivering ‘virtual’ hospital services to remote patients. Plus: data-sharing devices speed recovery; and AI’s role in managing US health claims becomes a legal minefield